- Home
- Publications
- Publication Search
- Publication Details
Title
C-Kit, a Double-Edged Sword in Liver Regeneration and Diseases
Authors
Keywords
-
Journal
Frontiers in Genetics
Volume 12, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2021-02-03
DOI
10.3389/fgene.2021.598855
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Single-cell gene profiling and lineage tracing analyses revealed novel mechanisms of endothelial repair by progenitors
- (2020) Jiacheng Deng et al. CELLULAR AND MOLECULAR LIFE SCIENCES
- Establishment of a PDX tumor from Hepatitis C Associated Liver Cancer and Evaluation of Imatinib Treatment Efficacy
- (2020) Mustafa Nazzal et al. HEPATOLOGY
- A human liver cell atlas reveals heterogeneity and epithelial progenitors
- (2019) Nadim Aizarani et al. NATURE
- Role of TGF-β1 and C-Kit Mutations in the Development of Hepatocellular Carcinoma in Hepatitis C Virus-Infected Patients: in vitro Study
- (2019) M. E. El-Houseini et al. BIOCHEMISTRY-MOSCOW
- Downregulation of hepatic stem cell factor by Vivo-Morpholino treatment inhibits mast cell migration and decreases biliary damage/senescence and liver fibrosis in Mdr2−/− mice
- (2019) Vik Meadows et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE
- Landscape and Dynamics of Single Immune Cells in Hepatocellular Carcinoma
- (2019) Qiming Zhang et al. CELL
- An acute immune response underlies the benefit of cardiac stem-cell therapy
- (2019) Ronald J. Vagnozzi et al. NATURE
- Mast Cells in Liver Fibrogenesis
- (2019) Ralf Weiskirchen et al. Cells
- Single-cell analysis reveals cancer stem cell heterogeneity in hepatocellular carcinoma
- (2018) Hongping Zheng et al. HEPATOLOGY
- Lenvatinib versus sorafenib in first-line treatment of patients with unresectable hepatocellular carcinoma: a randomised phase 3 non-inferiority trial
- (2018) Masatoshi Kudo et al. LANCET
- Overexpression of c-kit(CD117), relevant with microvessel density, is an independent survival prognostic factor for patients with HBV-related hepatocellular carcinoma
- (2018) Weiwei Yan et al. OncoTargets and Therapy
- Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
- (2018) Freddie Bray et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Genetic lineage tracing analysis of c-kit+ stem/progenitor cells revealed a contribution to vascular injury-induced neointimal lesions
- (2018) Qishan Chen et al. JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY
- Evaluation of NCAM and c-Kit as hepatic progenitor cell markers for intrahepatic cholangiocarcinomas
- (2018) Jing Xu et al. PATHOLOGY RESEARCH AND PRACTICE
- Mastocytosis-derived extracellular vesicles exhibit a mast cell signature, transfer KIT to stellate cells, and promote their activation
- (2018) Do-Kyun Kim et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Sphingosine-1-Phosphate Prevents Egress of Hematopoietic Stem Cells From Liver to Reduce Fibrosis
- (2017) Andrew King et al. GASTROENTEROLOGY
- Bile duct ligation-induced biliary hyperplasia, hepatic injury, and fibrosis are reduced in mast cell-deficient KitW-sh mice
- (2017) Laura Hargrove et al. HEPATOLOGY
- Regorafenib for patients with hepatocellular carcinoma who progressed on sorafenib treatment (RESORCE): a randomised, double-blind, placebo-controlled, phase 3 trial
- (2017) Jordi Bruix et al. LANCET
- Fibrosis in small syngeneic rat liver grafts because of damaged bone marrow stem cells from chronic alcohol consumption
- (2017) Masayuki Hisada et al. LIVER TRANSPLANTATION
- Randomized, open-label phase 2 study comparing frontline dovitinib versus sorafenib in patients with advanced hepatocellular carcinoma
- (2016) Ann-Lii Cheng et al. HEPATOLOGY
- A Positive TGF-β/c-KIT Feedback Loop Drives Tumor Progression in Advanced Primary Liver Cancer
- (2016) Andres Rojas et al. NEOPLASIA
- Randomized phase II study of axitinib versus placebo plus best supportive care in second-line treatment of advanced hepatocellular carcinoma
- (2015) Y.-K. Kang et al. ANNALS OF ONCOLOGY
- Telocytes in human liver fibrosis
- (2015) Siyi Fu et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- Hepatic Regenerative Potential of Mouse Bone Marrow Very Small Embryonic-Like Stem Cells
- (2015) Zhi-Hua Chen et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Promotion of Cancer Stem-Like Cell Properties in Hepatitis C Virus-Infected Hepatocytes
- (2015) Young-Chan Kwon et al. JOURNAL OF VIROLOGY
- A Rare Primary Liver Tumor That Responded to Sorafenib
- (2014) Satoshi Seino et al. GASTROENTEROLOGY
- Clinicopathologic Analysis of Combined Hepatocellular-Cholangiocarcinoma According to the Latest WHO Classification
- (2013) Jun Akiba et al. AMERICAN JOURNAL OF SURGICAL PATHOLOGY
- Nilotinib Interferes with the Signalling Pathways Implicated in Acetaminophen Hepatotoxicity
- (2013) Mohamed E. Shaker BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY
- In vitro proliferation and differentiation of hepatic oval cells and their potential capacity for intrahepatic transplantation
- (2013) Z. Li et al. BRAZILIAN JOURNAL OF MEDICAL AND BIOLOGICAL RESEARCH
- Distinct development and functions of resident and recruited liver Kupffer cells/macrophages
- (2013) Masami Ikarashi et al. JOURNAL OF LEUKOCYTE BIOLOGY
- Sorafenib in patients with Child-Pugh class A and B advanced hepatocellular carcinoma: a prospective feasibility analysis
- (2012) T. Pressiani et al. ANNALS OF ONCOLOGY
- Plasma Biomarkers as Predictors of Outcome in Patients with Advanced Hepatocellular Carcinoma
- (2012) J. M. Llovet et al. CLINICAL CANCER RESEARCH
- Clinicopathological analysis of 14 patients with combined hepatocellular carcinoma and cholangiocarcinoma
- (2012) Xian-Huan Yu et al. Hepatobiliary & Pancreatic Diseases International
- Background progenitor activation is associated with recurrence after hepatectomy of combined hepatocellular-cholangiocarcinoma
- (2012) Xiong Cai et al. HEPATOLOGY
- Modulation of Reparative Regeneration and CD117 Expression by Liver Cells after Partial Hepatectomy in Mice
- (2011) B. G. Yushkov et al. BULLETIN OF EXPERIMENTAL BIOLOGY AND MEDICINE
- Role of stem cell factor and granulocyte colony-stimulating factor in remodeling during liver regeneration
- (2011) Fanyin Meng et al. HEPATOLOGY
- Impaired function of bone marrow-derived endothelial progenitor cells in murine liver fibrosis
- (2011) Katsuya Shirakura et al. BioScience Trends
- Signaling of c-kit in dendritic cells influences adaptive immunity
- (2010) Prabir Ray et al. Annals of the New York Academy of Sciences
- The role of stem cell factor and c-KIT in keloid pathogenesis: do tyrosine kinase inhibitors have a potential therapeutic role?
- (2010) A. Mukhopadhyay et al. BRITISH JOURNAL OF DERMATOLOGY
- CCR2 mediates hematopoietic stem and progenitor cell trafficking to sites of inflammation in mice
- (2010) Yue Si et al. JOURNAL OF CLINICAL INVESTIGATION
- Transplantation of bone marrow cells reduces CCl4-induced liver fibrosis in mice
- (2010) Kyung-Ah Cho et al. LIVER INTERNATIONAL
- Masitinib, a c-kit/PDGF receptor tyrosine kinase inhibitor, improves disease control in severe corticosteroid-dependent asthmatics
- (2009) M. Humbert et al. ALLERGY
- Phase II Study of Imatinib in Unresectable Hepatocellular Carcinoma
- (2009) Albert Y. Lin et al. AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS
- Expression of stem cell factor receptor c-kit in human nontumoral and tumoral hepatic cells
- (2009) Tümen Mansuroglu et al. EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY
- Reduced exposure of imatinib after coadministration with acetaminophen in mice
- (2009) Ignacio Segarra et al. INDIAN JOURNAL OF PHARMACOLOGY
- Expression of stem cell factor and its receptor c-Kit during the development of intrahepatic cholangiocarcinoma
- (2009) Tümen Mansuroglu et al. LABORATORY INVESTIGATION
- Safety and efficacy of sunitinib in patients with advanced hepatocellular carcinoma: an open-label, multicentre, phase II study
- (2009) Sandrine Faivre et al. LANCET ONCOLOGY
- Stem cell factor and c-kit are involved in hepatic recovery after acetaminophen-induced liver injury in mice
- (2008) Bin Hu et al. AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY
- C-kit Inhibition by Imatinib Mesylate Attenuates Progenitor Cell Expansion and Inhibits Liver Tumor Formation in Mice
- (2008) Belinda Knight et al. GASTROENTEROLOGY
- Clinicopathological study on cholangiolocellular carcinoma suggesting hepatic progenitor cell origin
- (2008) Mina Komuta et al. HEPATOLOGY
- Participation of liver cancer stem/progenitor cells in tumorigenesis of scirrhous hepatocellular carcinoma—human and cell culture study
- (2008) Takahiko Fujii et al. HUMAN PATHOLOGY
- Expression of c-kit protooncogen in hepatitis B virus-induced chronic hepatitis, cirrhosis and hepatocellular carcinoma: has it a diagnostic role?
- (2008) B. Kara et al. INTERNATIONAL JOURNAL OF CLINICAL PRACTICE
- Efficacy and safety of sorafenib in patients in the Asia-Pacific region with advanced hepatocellular carcinoma: a phase III randomised, double-blind, placebo-controlled trial
- (2008) Ann-Lii Cheng et al. LANCET ONCOLOGY
- Sorafenib in Advanced Hepatocellular Carcinoma
- (2008) Josep M. Llovet et al. NEW ENGLAND JOURNAL OF MEDICINE
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started